UK’s regulatory and legislative double standards in the treatment of psychedelics and drugs for assisted suicide
The British Journal of Psychiatry · 17.07.2026 · 1-4
DOI: 10.1192/bjp.2026.10731 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 17.07.2026. Verfasst von Ruslan Zinchenko. Beteiligte Einrichtung: House of Lords, https://ror.org/03t61s708Parliament, London, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
This editorial highlights the UK’s drug regulatory double standards. Drugs for assisted suicide would bypass standard regulation despite limited evidence, while psychedelics face significant barriers despite promising evidence internationally. I argue that drugs for assisted suicide should meet the same regulatory standards, and psychedelics should be rescheduled to enable further clinical research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- House of Lords, https://ror.org/03t61s708Parliament, London, UK.
ORCID-Profile: Ruslan Zinchenko
Zitieren
APA
Zinchenko, R. (2026). UK’s regulatory and legislative double standards in the treatment of psychedelics and drugs for assisted suicide. The British Journal of Psychiatry, 1-4. https://doi.org/10.1192/bjp.2026.10731
Vancouver
Zinchenko R. UK’s regulatory and legislative double standards in the treatment of psychedelics and drugs for assisted suicide. The British Journal of Psychiatry. 2026:1-4. doi:10.1192/bjp.2026.10731
BibTeX
@article{Zinchenko2026,
author = {Zinchenko, Ruslan},
title = {UK’s regulatory and legislative double standards in the treatment of psychedelics and drugs for assisted suicide},
journal = {The British Journal of Psychiatry},
year = {2026},
pages = {1--4},
doi = {10.1192/bjp.2026.10731}
}
EUVIMED